This invention relates generally to medical electronic devices for analysis of auscultatory cardiac sounds. More particularly, this invention relates to a method for transducing, intelligently filtering, recording, analyzing and audiovisual representation of heart sounds at the point of care, in humans, to enable differential diagnosis.
Auscultatory sounds have long been one of the primary inputs to aid in the detection of various physiological conditions. For instance the stethoscope is the first tool used by a clinician to monitor heart sounds to detect and diagnose the condition of a subject's heart. Auscultation itself is extremely limited by a number of factors. It is extremely subjective and largely depends on the clinician's expertise in listening to the heart sounds and is compounded by the fact that certain components of the heart sounds are beyond the gamut of the human ear. In addition, auscultation relies on correctly determining which of the primary heart sounds correspond to the systolic and diastolic phases of the heart. This is made more difficult when conditions such as ectopic beats, atrial fibrillation, atrial flutter, tachycardia and various other rhythmic disorders occur.
A number of improvements have been developed to circumvent such bottlenecks, ranging from relatively noise-free electronic auscultation, to complex computer algorithms that can analyze the cardiac sounds, calculate various numerical values like heart rate, ascertain the heart sound phases, etc. For example, algorithms are available that allow heart sounds in electronic format to be visualized on a personal computer screen and analyzed.
Accordingly, personal computer (PC) based auscultatory devices like the Acoustic Cardioscan from Zargis Medical Corporation of Stamford, Conn., and software packages like the Veteran Phonocardiograph monitor from BioSignetics Corporation of Exeter, N.H., are capable of a wide range of operations and manipulations of heart sounds offline. However, the above described PC based platforms suffer from the following shortcomings and bottlenecks. These PC based systems call for a separate data gathering device to record heart sounds in the format that can be processed by the PC based algorithm. In addition, there is a critical time delay between the time the clinician auscultates the subject and the time the clinician applies the PC based analysis to the recorded heart sounds. There are also portability issues associated with the PC based system setup.
Currently, handheld auscultatory devices have been developed in an attempt to circumvent some of the above described problems with PC based computer systems. These handheld devices do incorporate the data gathering mechanism in the device itself, obviating the need for separate data gathering. Handheld devices sold under the brand names Cadiscope (from Caditec AG Medical Instruments of Switzerland) and the Visual Stethoscope (from MC21 Meditech Group) are instances of such handheld auscultatory devices. However handheld devices have their own shortcomings. For example, some handheld devices are designed such that the chest piece is housed in the device itself thereby rendering sterilization processes difficult, or at least call for involved and expensive methods of cleaning. Further, the mere display of the heart sounds or ECG signals, in addition to the audio of the heart sounds is insufficient for the user to ascertain the condition of the heart.
Particularly, there is a long felt and unmet need for the ability for such handheld auscultatory devices to dynamically alter the various filters used in processing the heart sounds. Such filtering, or ‘tuning’ may include user selection of filters, preset bands of filters and intelligent filtering.
It is therefore apparent that an urgent need exists for an improved auscultatory device that is easy to use, accurate, portable, cost-effective, tunable and easy to sterilize and maintain.
To achieve the foregoing and in accordance with the present invention, a method and system of tuning, analyzing and displaying heart sounds is provided. Such an auscultation system is useful for a clinician to efficiently and cost-effectively auscultate patients.
In some embodiments, the tunable auscultation system includes a heart sound transducer for sensing heart sounds from at least one chest location of the patient. The heart sounds are then passed through a circuit which pre-condition the signal. The pre-conditioning circuit consists of a pre-amplifier and an anti-aliasing filter.
These heart sounds are then sent to an analysis tool which performs a set of filtering processes. This tuning includes extracting pathology information.
The analysis tool is able to filter the frequencies of the heart sounds. The analysis tool is able to take in user input, perform intelligent tuning, and provide appropriate user feedback.
The user of the device is able to input a desired filter combination, consisting of either preset filter setups, e.g. low, medium, high, emphasize a certain feature such as S1 or S2, bell, diaphragm and various other settings whose frequencies are well known, or the user can set the center frequency and filter bandwidth as they desire, with or without the device providing guidance.
The intelligent tuning section consists of an algorithm that analyzes the signal, segments it into its various component parts, and extracts the segments of interest. The segments of interest can then be used by the algorithm to determine whether there is an underlying pathology. The intelligent tuning section can then pass this determination to the output section for user interaction.
The output of the stethoscope can consist of a signal strength indicator, a diagnosis indicator, the phonocardiogram and various methods of displaying a processed version of the phonocardiogram. The diagnosis indicator utilizes the information produced by the intelligent tuning section.
These and other features of the present invention will be described in more detail below in the detailed description of the invention and in conjunction with the following figures.
In order that the present invention may be more clearly ascertained, one embodiment will now be described, by way of example, with reference to the accompanying drawings, in which:
The present invention will now be described in detail with reference to several embodiments thereof as illustrated in the accompanying drawings. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. It will be apparent, however, to one skilled in the art, that the present invention may be practiced without some or all of these specific details. In other instances, well known process steps and/or structures have not been described in detail in order to not unnecessarily obscure the present invention. The features and advantages of the present invention may be better understood with reference to the drawings and discussions that follow.
To facilitate discussion,
Memory 140 can be fixed or removable memory, and combinations thereof. Examples of suitable technologies for memory 140 include solid-state memory such as flash memory, or a hard disk drive.
User interface 150 can be a keypad, a keyboard, a thumbwheel, a joystick, and combinations thereof. Video display 160 can be an LCD screen, or can be an LED display or a miniature plasma screen. It is also possible to combine video display 160 with user interface 150 by use of technologies such as a touch screen. Contrast and brightness control capability can also be added to display 160.
Audio input/output (I/O) device 170 includes a microphone, and speakers, earphones or headphones, any of which can be internal or external with respect to device 100. It is also possible to use wireless audio I/O devices such as a Bluetooth-based headset. Volume control of device 170 can also be provided.
In some embodiments, filter 320 is a pass band filter which limits the analysis of the heart sound signal to frequencies less than the maximum expected in a heart sound, thereby ensuring that all frequencies of the heart sounds are faithfully captured and at the same time eliminating noise sources that typically exist beyond the pass band of filter 320. Variable gain amplifier 330 of signal conditioner 120 serves to vary the signal gain based on a user-selectable input parameter, and also serves to ensure enhanced signal quality and improved signal to noise ratio. The conditioned heart sound signal after filtering and amplification is then provided to signal processor 350 via output buffer 350.
Multiple sets of filters of different frequencies pass bands pertain to a plurality of modes of operation. These modes include “Bell” mode, a “Diaphragm” mode, a low, medium and high filtration or additional frequency band pass preset. The bell and diaphragm operational modes emulate the respective functions of a combined Bell/Diaphragm head found in traditional acoustic (non-electronic) stethoscopes that many experienced clinicians are accustomed to using. The other filtration presets may be of particular use for identification of particular pathologies or sounds of interest. Depending on the user selection between audio playback mode and visual display mode, the pertinent set of audio or video filters is enabled.
Each of the normal and pathological heart sounds will have characteristic frequency content. These can be ordered on a continuum, for example like an analog radio dial from low to high. The user of the device can then dial through these bands in turn while listening to a subject's heart sounds, and observe its features. This may also be used in an educational setting as students are shown how to differentiate between features which sound similar but by separating into appropriate frequency bands, the various features can be extracted.
As shown in step 415, the user's visual analysis of the decomposed heart sounds is based on the filter mode selected through user interface 150.
For example,
In some embodiments, the frequencies captured in “Bell” mode include the complete range of Bell frequencies. Similarly the frequencies captured in “Diaphragm” mode include the complete range of the Diaphragm frequencies. Other customized decomposition modes with user definable component frequency ranges are also possible.
As discussed above, display 160, e.g., an LCD display, provides the visual representation of the heart sounds to the user by storing the waveforms in output buffer 350 prior to visual display (steps 440, 445). Meanwhile audio output device 170, e.g., a set of headphones, provides an auditory representation of the same heart sounds to the user by a digital-to-analog conversion (DAC) prior to audio playback (steps 470, 475). Preferably, both visual and auditory representations of the heart sounds as experienced by the user are synchronized.
In some embodiment, the sensor head has two opposing sensors (not shown), i.e., a Bell-side sensor and a Diaphragm-side sensor, like a traditional acoustic stethoscope. Accordingly, instead of the user manually selecting the Decomposition mode, device 100 automatically selects a default decomposition mode by sensing whether the Bell side sensor or the Diaphragm side sensor of the sensor head is touching the chest wall of the patient and hence is generating a stronger heart sound signal. The heart sounds are then analyzed by the corresponding Bell or Diaphragm filters which may also be automatically selected by processor 130. The user may be able to select additional filter modes, such as high/medium/low, etc. Selection of another filter mode may override the default filter selection in these embodiments.
In yet another embodiment illustrated by the isometric and top views of
Referring now to
As shown in
The user is able to ascertain pathologic heart conditions using device 100 because most conditions can be associated with their respective characteristic frequencies and amplitude durations. For example, under the right conditions, mitral value regurgitation can be diagnosed with approximately 60% certainty.
In some embodiments, the heart sound signals acquired by auscultation device 100 may be stored. For storage, the user selects the “Save” function by pressing keys on user interface 150, causing device 100 to download the heart sound signal, and associated patient identification and any annotation into a removable or an external memory device. In some embodiment, the patient ID and annotations can be added using voice recordings thereby minimizing the need for additional keystrokes. The local memory of device 100 can now be freed up for recording new heart sound signals.
In some embodiments, speech recognition technology known to one skilled in the art can be incorporated into device 100, enabling a textual record of the patient identification and annotations to be included instead or in addition to an audio recording. Speech recognition capability can also be used to activate the various functions of device 100, thereby resulting in a user-friendly and relatively hands-free auscultation device. Accuracy and/or efficiency of speech recognition can be increased by limiting the vocabulary and/or training the synthesizer to recognize the user's vocal characteristics.
It is also possible to incorporate speech synthesis capability into device 100 so as to enhance the ease of use with prompts, instructions and/or feedback. For example, device 100 can ask a user whether device 100 should be sensing in “Bell”, “Diaphragm”, or other filter preset mode, or to inform the user that an invalid command/mode has been selected.
Having described several of the functions of auscultation device 100 in detail,
In one embodiment as shown in
To conserve power, device 100 goes into a sleep mode if there are no key presses after a timeout period, e.g., after two minutes. While in this sleep mode, any key press causes device 100 to return to the last state of operation.
The user pre-selects a suitable duration of heart diagnosis, e.g., X seconds, of heart sound signals to be acquired. As illustrated by
Together with the user's training and experience, the “Original” heart sound 1064 enables the user to interpret the graphical representation of the complete heart waveforms, thereby providing the user with a general idea of the condition of the patient's heart. Note that device 100 initially displays the default audio volume level as an adjustable “Speaker” icon 1012, the default signal gain level as a “Dial” icon 1016, and the default zoom as a “Percentage” icon 1015 on video display 160.
At process 400, the user selects “Bell” or “Diaphragm” mode by pressing “Mode Select” key 1053, thereby causing device 100 to indicate the appropriate mode, in this example, “Diaphragm” 1014, on video display 160. When the user presses “Function Select” key 1052 to activate the “Decompose” function, which is followed by a lapse of X seconds, original heart sound 1067, and decomposed low frequency heart sound 1066 and high frequency heart sound 1065 are displayed by device 100. The decomposed heart sounds 1065, 1066 enable the user to identify the various heart sound phases and also to detect the presence of heart murmurs.
By manipulating the “Play/Pause” key 1059 as shown in step 500, the user causes device 100 to playback and/or record the heart sound signal, and also enables the user to select between “Normal” and “Stereophonic” playback modes.
After playback, the user has the option of saving the heart sounds in memory 140 for future analysis before initiating a new recording by pressing “Home” key 1051. The user can now initiate a new heart sound recording by pressing Function Select key 1054.
Other modifications to device 100 are also possible. As shown in
Whereas
Intelligent tuning may have two purposes. The first includes removing noise not associated with the cardiac cycle. For example, removing all breathing or movement related sounds. Additionally, ambient noises may be eliminated. The Auscultation Device may identify sounds not related to the cardiac cycle and remove, via intelligent filtering, those ‘non-signal’ sounds. Secondly, and more importantly, intelligent tuning may be implemented to suggest or automatically focus in on heart sound features indicative of a particular pathology.
In some embodiments, the Analysis Tool 1704 couples to a Display Module 1706 and Playback Module 1708. In some alternate embodiments, the Display Module 1706 and Playback Module 1708 may be combined into a single component; however, for the sake of clarity, these two modules are illustrated separately.
The Transducer 1702 is configured to acquire, and condition heart sounds. This conditioning may include pre-amplifying and perform antialiasing functions on the incoming heart sounds. The conditioned heart signals may then be presented to the Analysis Tool 1704 where specialized analysis may be performed. It is at the Analysis Tool 1704 that signal tuning may occur. Tuning may include filtering the heart signals, as well as performing data extraction from the signals, as will be explained in more detail below. The resulting tuned heart signals, and extracted data, may then be displayed by the Display Module 1706. Likewise, the Playback Module 1708 may, in some embodiments, be configured to playback the tuned heart signals and extracted data on demand at a later time.
The components of the Tunable Auscultation Device 1700 may be physically housed within a single device, such as a hand held Tunable Auscultation Device 1700. Alternatively, each component of the Tunable Auscultation Device 1700 may be separate physical entities which share heart signal data via wired, or wireless, data transfer.
The Acoustic Sensor 210 may include a traditional microphone, or may include a piezo sensor. The signals from the Acoustic Sensor 210 may then be sent to the Preamplifier 215 where pre-amplification occurs. The pre-amplified signal may then be sent to the Anti-Aliasing Filter 1804 where the signal is antialiased. As is well known by those skilled in the art, anti-aliasing is a technique of minimizing the distortion artifacts, known as aliasing, when representing a high-resolution signal at a lower resolution. This technique may remove the out-of-band component of the input signal prior to sampling with an analog-to-digital converter.
Output from the Anti-Aliasing Filter 1804 may be digitized and displayed through the Display Module 1706. Signal from the Anti-Aliasing Filter 1804 may be subjected to Digital Signal Processing (DSP) 1806a, 1806b, 1806c, 1806d and 1806x and displayed as External Signal Out 1808, Raw Signal Display 1810, Filtered Signal Display 1812, Audio Filtered Signal 1814 and Additional Display 1816, respectively.
One or more Digital Signal Processing (DSP) 1806a, 1806b, 1806c, 1806d and 1806x may perform filtering operations. Such filtering can be as simple as band-pass filters implemented as digital filters by defining the filter coefficients. However, the Digital Signal Processing (DSP) 1806a, 1806b, 1806c, 1806d and 1806x may also be much more sophisticated, such as wavelets, time-frequency analysis tools, or any other suitable analysis. Filters may be manually chosen by user operation, or the Tunable Auscultation Device 1700 may select filter bands based on an analysis of the input signal energy and contents.
External Signal Out 1808 may include, in some embodiments, a wired signal out. Additionally, the External Signal Out 1808 may be stored on an external memory, such as a flash card. Moreover, the External Signal Out 1808 may be wirelessly transmitted via Bluetooth, or any other suitable methodology, for external device reading. In the case of wireless transmission of the data, encryption may be utilized to ensure patient privacy and health data confidentiality.
The Raw Signal Display 1810 may display the heart sound signal in the native form, or may display conditioned heart signals. Raw Signal Display 1810 may include audio as well as visual display. Raw Signal Display 1810 may be of particular use when viewed in comparison to the Filtered Signal Display 1812.
In some embodiments, more than one Filtered Signal Display 1812 may be displayed as is desired. For example the physician may desire to display both a user selected Filtered Signal Display 1812 alongside an automatic Filtered Signal Display 1812.
Audio Filtered Signal 1814 may be played to the physician over a speaker or headphone style device. Additional Display 1816 is also contemplated as additional display methods become practical or desired.
The User Input Module 1902 may enable user tuning of the heart signals. The Intelligent Tuner 1904 may filter and perform data extraction on the heart signals. The Output Module 1906 may provide diagnosis, signal strength and frequency indication.
The Dynamic Range Selector 2002 may include, in some embodiments, a thumbwheel, dial, or other variable frequency range selector. The Preset Range Selector 2004 may include a set of selectors, such as buttons, enabled to set filtering to a preset frequency range. The frequency range presets may be pre-configured to provide appropriate filtering to identify particular disease states. Additionally, in some embodiments, the presets may be configurable by the physician.
The Feedback Module 2006 may provide the physician feedback as to frequency ranges selected, as well as suggested frequency domains or frequency presets.
Tuning may be temporal based. For example, the Tunable Auscultation Device 1700 may identify S1 and S2. The Tunable Auscultation Device 1700 may then identify sounds outside of where the S1 and S2 occur within the cycle. For example, if there is a sound existent in either the systolic or diastolic phase outside of the S1 and S2, the Tunable Auscultation Device 1700 can indicate to the user a possible murmur/S3/S4. Murmurs, for example, typically are sounds that occur between S1 and S2 or between S2 and S1. S3 and S4 occur at a given location within the cardiac cycle as well. The Tunable Auscultation Device 1700 may identify, via the temporal locations of these sounds, and indicate to the user that they may want to select a frequency band that emphasizes those particular sounds.
Likewise, tuning may be frequency based. The extraction algorithms may identify the various frequency bands that define particular pathologies. The relative energy of these bands may also be identified. From this information, the Tunable Auscultation Device 1700 may detect that a particular pathology exists. For example, in a normal, healthy heart, the frequency band 300-800 Hz may contain x % of energy. If the Tunable Auscultation Device 1700 detects that the energy in the band is above x % by a certain amount, it may indicate to the user/physician that pathology y might be present, and that the user may want to choose the appropriate frequency band to listen in more closely.
Moreover, tuning may be a combination of all of the above, where the Tunable Auscultation Device 1700 may clean up superfluous noise, look at the temporal and frequency signatures, and suggest to the user that they may want to listen to one or more particular frequency bands to determine whether certain pathologies are present.
The Audio Input/Output Device 170, the Frequency Indicator 2206, the Video Display 160, the Diagnosis Indicator 2216 and the Signal Strength Indicator 2214 in turn comprise the Display Module 1706.
The Sound Separator 2204 may provide raw and tuned heart sound signals to the Audio Input/Output Device 170 for audio output via a speaker or headphones. The Sound Separator 2204 may additionally drive the Frequency Indicator 2206, which may provide information on actual frequency ranges in conjunction audio output via a speaker or headphones.
The Output Driver 2208 drives the Waveform Differentiator 2210, Signal Strength Indicator 2214 and Diagnosis Indicator 2216. The Signal Strength Indicator 2214 may provide a visual indication of signal strength of the heart signal. The Signal Strength Indicator 2214 may provide overall signal strength indicia in some embodiments. Additionally, in some embodiments, the Signal Strength Indicator 2214 may provide signal strength by frequency range. Moreover, in some embodiments, the signal strength indicator may measure total signal strength and use this value to calibrate the relative signal strengths at particular frequencies. In some alternate embodiments, the physician may calibrate the base signal strength level for computing the signal strength by frequency range. The Signal Strength Indicator 2214 may provide strength indication via visual cues, such as LED lights, color “heat mapping”, LCD graphics, or other appropriate means.
The Diagnosis Indicator 2216 may utilize extracted information gained from the Algorithmic Extraction Engine 2104 via the Output Driver 2208 in order to provide a diagnosis. In some embodiments, the physician might input into the Tunable Auscultation Device 1700 that the patient may have a certain pathology. For example, patients with an artificial valve, prior medical diagnosis's, heart failure or operations may have their data inputted to provide for better diagnosis filtering. Additionally, information such as patient age, sex, ethnicity and body type may be inputted.
The Tunable Auscultation Device 1700 may then examine the temporal and frequency content of the heart sounds, and indicates a diagnosis. In some embodiments, the Tunable Auscultation Device 1700 may provide a statistical rating of the diagnosis, dependent upon the likelihood of a correct diagnosis. For example, the Diagnosis Indicator 2216 may provide a ‘positive’, ‘negative’ or ‘borderline’ diagnosis. In some alternate embodiments, the Diagnosis Indicator 2216 may provide a percentile rank of assurance of the veracity of the diagnosis.
Also, in some embodiments, the Diagnosis Indicator 2216 may provide suspected positional data regarding the location of possible pathologies. Such a function may be combined to include the aforementioned statistical rating of the likelihood of a correct diagnosis. In such embodiments, the Diagnosis Indicator 2216 may provide a graphical display where location on the display corresponds to location in the patient. Degree of shading on this graphical display may then designate relative signal strength, or likelihood of positive diagnosis.
The Waveform Differentiator 2210 may be configured to separate the tuned heart signal by waveform, or by cardiac cycle. The Waveform Differentiator 2210 may then couple to the Video Display 160 for display of multiple wave cycles. Showing multiple overlapped cycles enables the physician to detect if an event within a cardiac cycle is a one-off, irregular or regularly occurring heart sound.
The process then progresses to step 2306 where an inquiry is made as to whether tuning will be performed. If tuning is desired the process then progresses to step 2310 where signal tuning is completed. The process then progresses to step 2312 where the tuned audio signal is output. Lastly, at step 2314, the tuned signal is visually output. The process then ends.
Otherwise, if at step 2306 tuning is not desired, the process then progresses to step 2308 where standard processing occurs. The process then progresses to step 2312 where the standard non-tuned audio signal is output. Lastly, at step 2314, the tuned signal is visually output. The process then ends.
Output of the audio signal may include the output of the raw audio signal, as well as the tuned, or otherwise processed signal. Likewise, the output of the video data may include the raw signal as well as tuned, or otherwise processed signal. Additionally, the video output may include diagnosis indication, diagnosis location, signal strength, frequency indication, and multiple wave cycle display.
As previously noted, the Filter 320 may include a pass band filter which limits the analysis of the heart sound signal to frequencies expected in heart sounds, thereby ensuring that all frequencies of the heart sounds are faithfully captured and, at the same time, eliminating noise sources that typically exist beyond the pass band of Filter 320. The Variable Gain Amplifier 330 of Signal Conditioner 120 serves to vary the signal gain based on a user-selectable input parameter, and also serves to ensure enhanced signal quality and improved signal to noise ratio.
User Selected Filtering may, in some embodiments, be further classified as Presets and Continuous. For the continuous filter the user may specify frequency limits. These limits may be varied continuously with, say, a thumbwheel and with a feedback mechanism as described. Moreover, in some embodiments, the user may specify a center frequency and varying the bandwidth in a continuous fashion via similar mechanism as suggested above.
Otherwise, if at step 2502 user selected tuning is not desired, the process then progresses to step 2504 where automatic tuning is performed. The process then concludes by progressing to step 2312 of
The process then progresses to step 2604 where an inquiry is made as to whether an extraction is desired. If no extraction is desired, then the process then concludes by progressing to step 2312 of
Otherwise, if at step 2604 an extraction is desired, then the process may proceed to step 2606 where extraction algorithms are applied. The extraction algorithms may segment the incoming signal at step 2608. Then, at step 2610, the segments may each be analyzed for waveforms that would interest a physician. In this way pathologies and diagnoses may be generated. For example, a high frequency murmur may be identified in a low heart rate. At higher heart rates (e.g. tachycardia), the duration of the murmur will be less. In these situations, a simple filter typically loses the signal; however, by segmenting the heart signals by a time-frequency extraction algorithm, such indicia of murmur pathology may be extracted for a positive diagnosis.
Additionally, in some embodiments, extraction may include a simple homing directly into the strongest signal component automatically. For such an extraction a band pass filter with an appropriate pass band may be swept across the signal in a continuous fashion. Once a maximum output of the desired region is established, the band pass filter may then me centered around that frequency and the pass band is continuously adjusted until an optimum signal to noise is established—the noise power being estimated with a wide band filter setting. This optimum frequency location and band width may then be used to display a filtered signal. This process can be repeated serially or simultaneously for multiple frequency regions, each corresponding to a particular set of pathologies or indications.
After extraction the process then concludes by progressing to step 2312 of
Else, if no user presets are desired at step 2702, the process then progresses to step 2704 where the user manually selects the frequency range. This may be enabled via thumbwheel or dial, which allows the frequency range selection to be continuous. The process then progresses to step 2708 where feedback is provided to the user selection. Again, such feedback may include indicia of the frequency chosen, as well as suggested frequency ranges, in the manner discussed above. The process then concludes by progressing to step 2312 of
At step 2806 the energy content in a chosen band may be displayed. As previously noted, energy content may be given for the entire heart signal, or for a particular frequency band. Energy content for a frequency band may be given in a raw form, such as in recorded decibels (dB), or may be calibrated for relative energy content. In some embodiments, the calibration may utilize the overall signal strength to provide a base signal level. In some embodiments, the physician may manually configure the base signal level for the calibration. Energy content may be displayed in any suitable manner. For example a tri-color LED may be utilized, where energy content is displayed in terms of positive, negative or borderline. Another example would include graphical bars on a LCD, or equivalent, display.
At step 2808 a diagnosis indication may be displayed. As previously mentioned, pathologies may be identified through extraction analysis utilizing extraction algorithms. A diagnosis may then be displayed for these pathologies. In some embodiments, the diagnosis may include a simple ‘positive’, ‘negative’ or ‘borderline’ indication. In yet another embodiment, the diagnosis indicator may provide a statistical likelihood of the correctness of the diagnosis. This indication may include a percentile rating, color coding or other acceptable means.
At step 2810 the diagnosis location may be displayed. By moving the Tunable Auscultation Device 1700 to different locations on the patient a positional map of the sensed pathology may be generated. By inclusion of accelerometers within the Tunable Auscultation Device 1700, movement and position of the Tunable Auscultation Device 1700 may be determined. This positional data may then be cross referenced by the extraction data to generate a diagnosis location map. In some embodiments, the Tunable Auscultation Device 1700 may omit accelerometers or other location sensing components. In such embodiments the physician may be required to move the Tunable Auscultation Device 1700 in a predetermined pattern in order to link the sensed heart sounds to a location. The diagnosis location map may then be utilized to generate the display of diagnosis location. Such a display may include a shaded display indicating the strength of a suspected pathology.
At step 2812 overlapping signals may be displayed. The heart signal may be divided into cardiac cycles, and subsequent cycles may be displayed in tandem. By displaying multiple cycles the physician may be able to determine if a detected event is one-off, irregular or regularly occurring. The process then ends.
The Control Interface 2906 may include an Annunciator 2908, Power Control 2910, Modality Control 2912, Tuning Control 2914 and Wireless Indicator 2916. The Annunciator 2908 may include a LED array, LCD screen or other appropriate display type. The Power Control 2910 may control both wireless connectivity as well as Handheld Tunable Auscultation Device 2900 power options. For example, a prolonged ‘press and hold’ of the Power Control 2910 may power cycle the Handheld Tunable Auscultation Device 2900, while a simple press of the Power Control 2910 may cycle the wireless power.
The Modality Control 2912 may toggle Bell versus diaphragm modality. The Annunciator 2908 may provide indication of the mode selected.
The Tuning Control 2914 may provide user tuning selection. The Annunciator 2908 may provide information as to tuning selection and selection feedback. The Tuning Control 2914 may include a thumbwheel, dial or other interface. For example, a voice activated, or remotely activated interface is considered.
Lastly, the Wireless Indicator 2916 may provide indication of wireless connectivity. For example, the Wireless Indicator 2916 may include a LED that rapidly flashes during wireless connection. The Wireless Indicator 2916 may then remain on during connection. In cases that the Handheld Tunable Auscultation Device 2900 cannot connect wirelessly, the Wireless Indicator 2916 may blink slowly. In another example, the Wireless Indicator 2916 may include a multicolored LED that may indicate wireless connectivity strength dependent upon color.
In sum, Tunable Auscultation Device 1700 provides many advantages over the existing auscultatory devices, including intelligent tuning for diagnosis. The systems and methods illustrated may be embodied as entirely software, entirely hardware or a combination thereof.
While the present invention has been described with reference to particular embodiments, it will be understood that the embodiments are illustrative and that the invention scope is not so limited. In addition, the various features of the present invention can be practiced alone or in combination. Alternative embodiments of the present invention will also become apparent to those having ordinary skill in the art to which the present invention pertains. Such alternate embodiments are considered to be encompassed within the spirit and scope of the present invention. Accordingly, the scope of the present invention is described by the appended claims and is supported by the foregoing description.
Number | Date | Country | Kind |
---|---|---|---|
772/CHE/2006 | Apr 2006 | IN | national |
This is a continuation-in-part of co-pending U.S. application Ser. No. 11/740,906 filed on Apr. 26, 2007, entitled “Systems and Methods for Analysis and Display of Heart Sounds”, which is hereby fully incorporated by reference.
Number | Date | Country | |
---|---|---|---|
60833385 | Jul 2006 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11740906 | Apr 2007 | US |
Child | 12109346 | US |